Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV ‐1‐infected subjects with dyslipidaemia

ConclusionsCobicistat as a booster of darunavir in HIV‐infected subjects had a beneficial effect on the lipid profile in patients with hypercholesterolaemia or hypertrigliceridaemia at baseline.

Source: HIV Medicine - July 1, 2017 Category: Infectious Diseases Authors: P Echeverr ía, A Bonjoch, J Puig, A Ornella, B Clotet, E Negredo Tags: Short Communication Source Type: research